Nama Insights

Warby Parker (WRBY)

Healthcare · Medical Instruments Supplies · NYSE

Warby Parker (WRBY) is a Healthcare company in the Medical Instruments Supplies industry. It has a market capitalization of $3.00B, a trailing price-to-earnings ratio of 60.3 and a free-cash-flow yield of 1.5%. Over the most recent reported fiscal year, revenue grew 13.0% and free cash flow per share grew 23.6%. Nama's AI scorecard rates it Hold, 5.3 out of 10. On 12-month momentum it ranks in the rising band of its market.
AI scorecard
Hold · 5.3/10
The sections balance. As of Nov 20, 2026.
Momentum
Rising · +50.7% over 12 months ex. last
Second-best fifth of its market on the past year's move.
Shariah screen
Shariah Compliant
Passes our debt, cash and income screen; not a scholar's ruling.
Off its high
-59.1%
How far the last close sits under the highest price of the past five years.
Market cap$3.00B
Trailing P/E60.3
Price / book7.4
Price / sales3.2
FCF yield1.5%
Dividend yield—
Gross margin54.8%
Operating margin0.2%
Net margin0.8%
Revenue growth (YoY)+13.0%
Revenue growth (3-yr annual)+13.4%
EPS growth (YoY)+28.6%
FCF/share growth (YoY)+23.6%
Beta1.9
ExchangeNYSE
SectorHealthcare
IndustryMedical Instruments Supplies

WRBY earnings

Next report: Feb 25, 2027 (Q4 2026, EPS estimate $0.09). Beat the EPS estimate in 2 of 4 recent quarters.

QuarterReportedEPSEstimateSurpriseRevenue
Q3 2026 Nov 5, 2026 $0.12 $0.09 +33.3% $244.74M
Q2 2026 Aug 6, 2026 $0.15 $0.11 +36.4% $235.51M
Q1 2026 May 7, 2026 $0.11 $0.11 +0.0% $242.45M
Q4 2025 Feb 26, 2026 $0.02 $0.05 -60.0% $211.97M

WRBY analyst price target

Median target $32.00 from 12 analysts, ranging $25.00 – $40.00.

Medical Instruments Supplies peers

TickerCompanyMarket capP/E
ISRG Intuitive Surgical $141.17B 37.6
BDX Becton, Dickinson $57.93B 16.1
MDLN Medline $49.80B 23.9
ALC Alcon $35.79B 22.0
RMD ResMed $33.32B 20.5
WST West Pharmaceutical Services $27.63B 43.1
SOLV Solventum $14.58B 12.2
BAX Baxter International $13.14B 13.1
Explore live WRBY data on Nama Insights →

WRBY FAQ

Is WRBY a buy?
Nama's AI scorecard currently rates Warby Parker Hold (5.3 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.
What is WRBY's P/E ratio?
Warby Parker trades at a trailing price-to-earnings ratio of 60.3.
When does WRBY report earnings?
Warby Parker's next scheduled report is on Feb 25, 2027. Analysts expect EPS of $0.09.
What is the WRBY price target?
The median analyst price target from 12 analysts is $32.00, with a range of $25.00 – $40.00.
Is WRBY Shariah compliant?
Nama's AAOIFI-style screen reads Warby Parker as Shariah Compliant. Passes our debt, cash and income screen; not a scholar's ruling.